Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-25-038884
Filing Date
2025-03-13
Accepted
2025-03-13 17:17:25
Documents
99
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K stro-20241231.htm   iXBRL 10-K 4646793
2 EX-19.1 stro-ex19_1.htm EX-19.1 152196
3 EX-23.1 stro-ex23_1.htm EX-23.1 14292
4 EX-31.1 stro-ex31_1.htm EX-31.1 16520
5 EX-31.2 stro-ex31_2.htm EX-31.2 16907
6 EX-32.1 stro-ex32_1.htm EX-32.1 8346
7 EX-32.2 stro-ex32_2.htm EX-32.2 8376
8 GRAPHIC img142475726_0.jpg GRAPHIC 30400
9 GRAPHIC img142475726_1.jpg GRAPHIC 18911
10 GRAPHIC img142475726_2.jpg GRAPHIC 21842
11 GRAPHIC img142475726_3.jpg GRAPHIC 245365
  Complete submission text file 0000950170-25-038884.txt   17691067

Data Files

Seq Description Document Type Size
12 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT stro-20241231.xsd EX-101.SCH 2129348
102 EXTRACTED XBRL INSTANCE DOCUMENT stro-20241231_htm.xml XML 3222501
Mailing Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 650-392-8412
SUTRO BIOPHARMA, INC. (Filer) CIK: 0001382101 (see all company filings)

EIN.: 452441988 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38662 | Film No.: 25736870
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)